RE Dickinson Investment Advisors’s AbbVie ABBV Stock Holding History

RE Dickinson Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$172K	Buy	965 +1	+0.1%	+$184	0.1%	53
2024 Q3	$190K	Hold	964	–	–	0.11%	49
2024 Q2	$165K	Hold	964	–	–	0.1%	54
2024 Q1	$176K	Hold	964	–	–	0.11%	48
2023 Q4	$149K	Hold	964	–	–	0.1%	49
2023 Q3	$144K	Hold	964	–	–	0.1%	50
2023 Q2	$130K	Hold	964	–	–	0.05%	105
2023 Q1	$154K	Hold	964	–	–	0.05%	100
2022 Q4	$156K	Hold	964	–	–	0.06%	88
2022 Q3	$250K	Hold	964	–	–	0.21%	34
2022 Q2	$147K	Hold	964	–	–	0.02%	48
2022 Q1	$156K	Buy	964 +59	+7%	+$8.57K	0.1%	46
2021 Q4	$123K	Buy	+905	New	+$107K	0.09%	49

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RE Dickinson Investment Advisors's ABBV Position: Q4 2024 in Review

RE Dickinson Investment Advisors increased its AbbVie (ABBV) stake by 0.1% in Q4 2024, buying an estimated $184 and bringing the position to 965 shares worth $172K. The position accounts for 0.1% of the portfolio, ranked #53.

RE Dickinson Investment Advisors first reported a position in ABBV in Q4 2021 and has held it in 13 quarters since. The position peaked at $250K in Q3 2022. 3,750 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

RE Dickinson Investment Advisors held 965 shares of AbbVie worth $172K as of Q4 2024.
RE Dickinson Investment Advisors bought 1 AbbVie share in Q4 2024, an estimated $184.
AbbVie made up 0.1% of RE Dickinson Investment Advisors's portfolio in Q4 2024, its #53 holding.
RE Dickinson Investment Advisors first reported a position in AbbVie in Q4 2021 and has held it in 13 quarters since.
RE Dickinson Investment Advisors's AbbVie position peaked at $250K in Q3 2022.
3,750 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on RE Dickinson Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.